Instem PLC
LSE:INS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Instem PLC
Revenue
Instem PLC
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Instem PLC
LSE:INS
|
Revenue
ÂŁ57.6m
|
CAGR 3-Years
31%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
|
|
Renalytix PLC
LSE:RENX
|
Revenue
$3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Revenue
$205.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
24%
|
CAGR 10-Years
16%
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Revenue
ÂŁ9.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Revenue
ÂŁ39.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
P
|
Physitrack PLC
STO:PTRK
|
Revenue
€16.2m
|
CAGR 3-Years
24%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
Instem PLC
Glance View
Instem Plc engages in the provision of information technology solutions and services to the global health and life sciences community. The company is headquartered in Stone, Staffordshire and currently employs 304 full-time employees. The company went IPO on 2010-10-13. The firm operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trials Acceleration. Its Study Management Solutions is a software that enables organizations to collect, review, manage and report discovery and preclinical report. Its Regulatory Solutions is a software, outsourced services and consultancy for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The firm's In Silico Solutions enables researchers to generate scientific insights through identification, extraction and analysis of information. Its Clinical Trials Acceleration Solutions is a technology solution and consulting service to facilitate data integration, statistics, analytics and insights for companies any size or stage of clinical trial analysis.
See Also
What is Instem PLC's Revenue?
Revenue
57.6m
GBP
Based on the financial report for Dec 31, 2022, Instem PLC's Revenue amounts to 57.6m GBP.
What is Instem PLC's Revenue growth rate?
Revenue CAGR 10Y
18%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Instem PLC have been 31% over the past three years , 22% over the past five years , and 18% over the past ten years .